AbCellera Biologics Inc. (ABCL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 8.31M | 44.85M | 8.96M | 17.08M | 4.24M | 5.05M | 6.51M | 7.32M | 9.95M | 9.18M | 6.6M | 10.06M |
| Revenue Growth % | 96.34% | 788.18% | 37.62% | 133.29% | -57.45% | -44.98% | -1.39% | -27.18% | -18.36% | -57.4% | -93.49% | -78.1% |
| Cost of Goods Sold | 8.65M | 7.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 104.09% | 17.66% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -340K | 36.93M | 8.96M | 17.08M | 4.24M | 5.05M | 6.51M | 7.32M | 9.95M | 9.18M | 6.6M | 10.06M |
| Gross Margin % | -4.09% | 82.34% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -108.03% | 631.35% | 37.62% | 133.29% | -57.45% | -44.98% | -1.39% | -27.18% | -18.36% | -54.08% | -92.36% | -75.3% |
| Operating Expenses | 57.18M | 65.52M | 85.23M | 66.67M | 66.89M | 77.81M | 100.17M | 100.78M | 64.85M | 75.23M | 61.49M | 61.45M |
| OpEx % of Revenue | 687.66% | 146.07% | 951.79% | 390.24% | 1579.58% | 1540.69% | 1539.42% | 1376.17% | 651.48% | 819.61% | 931.79% | 611.03% |
| Selling, General & Admin | 10.52M | 15.42M | 24.96M | 21.99M | 19.07M | 19.16M | 22.28M | 23.33M | 20.72M | 19.07M | 17.84M | 19.36M |
| SG&A % of Revenue | 126.48% | 34.38% | 278.7% | 128.69% | 450.25% | 379.49% | 342.43% | 318.56% | 208.13% | 207.8% | 270.3% | 192.54% |
| Research & Development | 46.66M | 50.09M | 55.03M | 39.21M | 42.5M | 46.08M | 40.97M | 40.93M | 39.29M | 48.62M | 37.92M | 36.47M |
| R&D % of Revenue | 561.18% | 111.68% | 614.49% | 229.53% | 1003.45% | 912.4% | 629.61% | 558.88% | 394.69% | 529.71% | 574.59% | 362.7% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -57.52M | -28.58M | -76.28M | -49.59M | -62.66M | -72.75M | -93.66M | -93.45M | -54.89M | -66.05M | -54.89M | -51.39M |
| Operating Margin % | -691.75% | -63.72% | -851.79% | -290.24% | -1479.58% | -1440.69% | -1439.42% | -1276.17% | -551.48% | -719.61% | -831.79% | -511.03% |
| Operating Income Growth % | 8.2% | 60.71% | 18.56% | 46.94% | -14.15% | -10.15% | -70.64% | -81.86% | 15.38% | -74.85% | -245.46% | -512.07% |
| EBITDA | -48.86M | -20.66M | -69.04M | -42.52M | -56.05M | -58.85M | -55.37M | -55.42M | -48.13M | -56.94M | -47.48M | -44.13M |
| EBITDA Margin % | -587.66% | -46.07% | -770.99% | -248.92% | -1323.61% | -1165.45% | -850.9% | -756.75% | -483.5% | -620.37% | -719.52% | -438.87% |
| EBITDA Growth % | 12.83% | 64.89% | -24.7% | 23.26% | -16.47% | -3.36% | -16.61% | -25.57% | 16.67% | -154.01% | -206.79% | -1774.01% |
| D&A (Non-Cash Add-back) | 8.65M | 7.92M | 7.24M | 7.06M | 6.61M | 13.9M | 38.3M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M |
| EBIT | -57.52M | -28.58M | -73.55M | -45.89M | -58.51M | -69.21M | -90.17M | -90.14M | -51.62M | -62.68M | -52.06M | -46.81M |
| Net Interest Income | 3.64M | 5.92M | 6.76M | 7.59M | 8.05M | 8.67M | 9.6M | 9.8M | 10.4M | 10.97M | 10.74M | 10.78M |
| Interest Income | 3.64M | 5.92M | 6.76M | 7.59M | 8.05M | 8.67M | 9.6M | 9.8M | 10.4M | 10.97M | 10.74M | 10.78M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 7.98M | 9.08M | 7.51M | 13.24M | 9.68M | 25.93M | 31.03M | 45.27M | 12.15M | 17.45M | 15.61M | 13.38M |
| Pretax Income | -49.54M | -19.5M | -68.77M | -36.34M | -52.98M | -46.83M | -62.63M | -48.19M | -42.75M | -48.6M | -39.28M | -38M |
| Pretax Margin % | -595.75% | -43.47% | -767.93% | -212.74% | -1251.1% | -927.31% | -962.53% | -658.02% | -429.45% | -529.49% | -595.18% | -377.92% |
| Income Tax | -6.37M | -10.55M | -11.65M | -1.62M | -7.36M | -12.62M | -11.53M | -11.26M | -2.14M | -1.45M | -10.67M | -7.48M |
| Effective Tax Rate % | 12.86% | 54.13% | 16.94% | 4.45% | 13.9% | 26.95% | 18.4% | 23.36% | 5% | 2.99% | 27.16% | 19.67% |
| Net Income | -43.16M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M |
| Net Margin % | -519.12% | -19.94% | -637.84% | -203.27% | -1077.24% | -677.43% | -785.42% | -504.3% | -407.98% | -513.67% | -433.55% | -303.58% |
| Net Income Growth % | 5.38% | 73.85% | -11.76% | 5.97% | -12.34% | 27.44% | -78.63% | -20.97% | -1.25% | -57.73% | -207.46% | -349.93% |
| Net Income (Continuing) | -43.16M | -8.95M | -57.12M | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.10 | -0.11 |
| EPS Growth % | 6.67% | 75% | -11.76% | 7.69% | -7.14% | 25% | -70% | -18.18% | 0% | -61.29% | -225% | -450% |
| EPS (Basic) | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 | -0.13 | -0.14 | -0.16 | -0.10 | -0.11 |
| Diluted Shares Outstanding | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M |
| Basic Shares Outstanding | 303.07M | 298.71M | 298.88M | 298.51M | 297.69M | 294.59M | 294.85M | 294.22M | 292.72M | 290.95M | 289.5M | 288.91M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |